| 2020 |
| 09/24 | 17:55 ファシリティ契約に基づく第10回新株予約権(行使価額修正条項付)の行使停止要請通知に関するお知らせ |
| 09/23 | 382 | 384 | 364 | 364 | -2.67% | 2,185,900 | 95億7760万 | -3.19% |
| 09/18 | 15:30 第10回新株予約権(行使価額修正条項付)の大量行使に関するお知らせ |
| 09/18 | 459 | 459 | 373 | 374 | -1.32% | 6,811,900 | 98億4072万 | -0.53% |
| 09/17 | 15:30 米国Glaukos社との共同研究の対象疾患の追加並びに新たなライセンス契約締結のお知らせ |
| 09/17 | 390 | 390 | 375 | 379 | -2.82% | 102,200 | 99億7228万 | +0.53% |
| 09/16 | 379 | 392 | 377 | 390 | +2.9% | 158,700 | 102億6171万 | +3.45% |
| 09/15 | 373 | 381 | 372 | 379 | +1.07% | 77,900 | 99億7228万 | +0.8% |
| 09/14 | 376 | 379 | 374 | 375 | -0.53% | 55,600 | 98億6703万 | -0.27% |
| 09/11 | 372 | 379 | 369 | 377 | +0.8% | 88,700 | 99億1966万 | 0% |
| 09/10 | 372 | 375 | 369 | 374 | -0.27% | 82,500 | 98億4072万 | -0.8% |
| 09/09 | 369 | 376 | 369 | 375 | -0.27% | 83,200 | 98億6703万 | -0.53% |
| 09/08 | 366 | 377 | 363 | 376 | +2.17% | 118,800 | 98億9334万 | -0.27% |
| 09/07 | 372 | 372 | 363 | 368 | -1.6% | 157,900 | 96億8285万 | -2.39% |
| 09/04 | 371 | 376 | 369 | 374 | -0.8% | 75,900 | 98億4072万 | -0.53% |
| 09/03 | 376 | 378 | 370 | 377 | +1.07% | 51,500 | 99億1966万 | +0.27% |
| 09/02 | 380 | 380 | 370 | 373 | -2.1% | 104,500 | 98億1441万 | -0.8% |
| 09/01 | 15:30 第10回新株予約権(行使価額修正条項付)の月間行使状況に関するお知らせ |
| 09/01 | 370 | 381 | 368 | 381 | +2.7% | 132,900 | 100億2491万 | +1.33% |
| 08/31 | 371 | 376 | 367 | 371 | +1.37% | 127,100 | 97億6178万 | -1.07% |
| 08/28 | 399 | 401 | 361 | 366 | -2.4% | 514,400 | 96億3022万 | -2.92% |
| 08/27 | 15:00 主要株主の異動に関するお知らせ |
| 08/27 | 15:00 神経疼痛治療薬「DW-5LBT」の米国における承認申請のお知らせ |
| 08/27 | 389 | 391 | 372 | 375 | -2.6% | 181,600 | 98億6703万 | -1.06% |
| 08/26 | 11:30 緑内障・高眼圧症治療剤「K-115」(国内製品名:グラナテック点眼液0.4%)のタイにおける承認取得のお知らせ |
| 08/26 | 371 | 395 | 371 | 385 | +3.49% | 223,300 | 101億3015万 | +1.32% |
| 08/25 | 372 | 375 | 369 | 372 | -0.27% | 87,400 | 97億8810万 | -2.11% |
| 08/24 | 383 | 383 | 368 | 373 | -1.84% | 96,500 | 98億1441万 | -2.36% |
| 08/21 | 383 | 383 | 376 | 380 | -0.78% | 110,400 | 99億9859万 | -1.04% |
| 08/20 | 385 | 392 | 381 | 383 | -1.79% | 105,100 | 100億7753万 | -0.52% |
| 08/19 | 371 | 390 | 371 | 390 | +4.84% | 167,800 | 102億6171万 | +1.04% |
| 08/18 | 370 | 373 | 364 | 372 | +1.09% | 132,100 | 97億8810万 | -3.88% |
| 08/17 | 381 | 383 | 366 | 368 | -3.66% | 124,700 | 96億8285万 | -5.15% |
| 08/14 | 375 | 386 | 375 | 382 | +0.79% | 82,100 | 100億5122万 | -2.3% |
| 08/13 | 15:30 2020年12月期第2四半期決算説明資料 |
| 08/13 | 15:30 2020年12月期第2四半期決算短信〔日本基準〕(連結) |
| 08/13 | 383 | 384 | 379 | 379 | -1.04% | 90,400 | 99億7228万 | -3.32% |
| 08/12 | 381 | 384 | 375 | 383 | +0.26% | 91,300 | 100億7753万 | -2.79% |
| 08/11 | 373 | 384 | 373 | 382 | +1.06% | 102,800 | 100億5122万 | -3.29% |
| 08/07 | 15:00 第三者割当による第10回新株予約権(行使価額修正条項付)の発行に係る払込完了に関するお知らせ |
| 08/07 | 371 | 378 | 364 | 378 | +0.53% | 119,600 | 99億4597万 | -4.55% |
| 08/06 | 393 | 393 | 373 | 376 | -3.84% | 119,300 | 98億9334万 | -5.53% |
| 08/05 | 382 | 391 | 374 | 391 | +2.62% | 163,900 | 102億8803万 | -2.25% |
| 08/04 | 366 | 381 | 366 | 381 | +3.53% | 127,600 | 100億2491万 | -5.22% |
| 08/03 | 344 | 373 | 344 | 368 | +6.98% | 122,600 | 96億8285万 | -9.36% |
| 07/31 | 360 | 369 | 340 | 344 | -6.52% | 288,100 | 90億5136万 | -16.1% |
| 07/30 | 376 | 376 | 366 | 368 | -0.81% | 69,700 | 96億8285万 | -11.54% |
| 07/29 | 372 | 376 | 368 | 371 | -0.8% | 110,300 | 97億6178万 | -11.67% |
| 07/28 | 375 | 380 | 369 | 374 | +0.81% | 149,700 | 98億4072万 | -12% |
| 07/27 | 387 | 395 | 370 | 371 | -9.95% | 535,900 | 97億6178万 | -13.52% |
| 07/22 | 20:00 (訂正)「第三者割当による第10回新株予約権発行に関する補足説明資料」の一部訂正について |
| 07/22 | 15:30 第三者割当による第10回新株予約権発行に関する補足説明資料 |
| 07/22 | 15:30 第三者割当による第10回新株予約権(行使価額修正条項付)の発行及びファシリティ契約(行使停止指定条項付)の締結に関するお知らせ |
| 07/22 | 407 | 412 | 401 | 412 | +0.49% | 51,100 | 108億4058万 | -4.85% |
| 07/21 | 403 | 412 | 402 | 410 | +1.74% | 71,600 | 107億8796万 | -5.96% |
| 07/20 | 399 | 405 | 394 | 403 | +1.26% | 67,900 | 106億377万 | -7.99% |
| 07/17 | 407 | 409 | 393 | 398 | -2.69% | 181,700 | 104億7221万 | -9.55% |
| 07/16 | 419 | 419 | 409 | 409 | -2.39% | 118,400 | 107億6164万 | -7.67% |
| 07/15 | 416 | 426 | 414 | 419 | +1.21% | 227,900 | 110億2476万 | -6.05% |
| 07/14 | 425 | 433 | 408 | 414 | 0% | 315,100 | 108億9320万 | -8% |
| 07/13 | 15:00 緑内障・高眼圧症治療剤「K-115」(国内製品名:グラナテック点眼液0.4%)のマレーシアにおける承認取得のお知らせ |
| 07/13 | 408 | 415 | 401 | 414 | +2.73% | 66,300 | 108億9320万 | -8.81% |
| 07/10 | 406 | 417 | 403 | 403 | -1.95% | 105,900 | 106億377万 | -11.82% |
| 07/09 | 427 | 427 | 406 | 411 | -4.42% | 241,400 | 108億1427万 | -10.85% |
| 07/08 | 416 | 435 | 416 | 430 | +2.14% | 78,500 | 113億1420万 | -7.53% |
| 07/07 | 429 | 429 | 412 | 421 | -0.24% | 130,900 | 110億7739万 | -9.66% |
| 07/06 | 414 | 425 | 410 | 422 | +1.93% | 124,800 | 111億370万 | -9.83% |
| 07/03 | 402 | 420 | 402 | 414 | +2.48% | 94,000 | 108億9320万 | -11.91% |
| 07/02 | 422 | 426 | 399 | 404 | -4.04% | 298,500 | 106億3008万 | -14.41% |
| 07/01 | 444 | 444 | 421 | 421 | -3.44% | 153,600 | 110億7739万 | -11.18% |
| 06/30 | 444 | 452 | 424 | 436 | -0.91% | 169,900 | 114億7207万 | -8.4% |
| 06/29 | 452 | 459 | 437 | 440 | -4.56% | 200,900 | 115億7732万 | -7.56% |
| 06/26 | 481 | 485 | 458 | 461 | -3.56% | 193,500 | 121億2987万 | -3.56% |
| 06/25 | 481 | 490 | 477 | 478 | -1.44% | 130,800 | 125億7718万 | +0.21% |
| 06/24 | 484 | 488 | 475 | 485 | +0.62% | 278,200 | 127億6136万 | +2.11% |
| 06/23 | 492 | 497 | 474 | 482 | -1.23% | 206,600 | 126億8243万 | +1.9% |
| 06/22 | 480 | 493 | 480 | 488 | +0.83% | 156,700 | 128億4030万 | +3.83% |
| 06/19 | 470 | 487 | 468 | 484 | +2.76% | 206,600 | 127億3505万 | +3.42% |
| 06/18 | 475 | 485 | 464 | 471 | -1.67% | 179,600 | 123億9299万 | +1.51% |
| 06/17 | 471 | 480 | 466 | 479 | +1.48% | 167,500 | 126億349万 | +3.9% |
| 06/16 | 467 | 479 | 458 | 472 | +6.55% | 213,100 | 124億1931万 | +2.83% |
| 06/15 | 472 | 479 | 438 | 443 | -5.94% | 334,800 | 116億5626万 | -3.06% |
| 06/12 | 450 | 483 | 450 | 471 | -3.29% | 368,400 | 123億9299万 | +3.52% |
| 06/11 | 514 | 524 | 486 | 487 | -6.17% | 678,800 | 128億1399万 | +7.74% |
| 06/10 | 514 | 528 | 503 | 519 | +1.57% | 693,100 | 136億5597万 | +15.59% |
| 06/09 | 490 | 513 | 487 | 511 | +4.5% | 704,700 | 134億4548万 | +15.09% |
| 06/08 | 509 | 512 | 487 | 489 | -2.78% | 589,900 | 128億6661万 | +11.39% |
| 06/05 | 503 | 505 | 481 | 503 | -0.98% | 780,800 | 132億3498万 | +15.63% |
| 06/04 | 470 | 525 | 461 | 508 | +8.78% | 2,096,400 | 133億6654万 | +18.14% |
| 06/03 | 479 | 481 | 462 | 467 | -1.89% | 250,300 | 122億8775万 | +10.14% |
| 06/02 | 464 | 479 | 462 | 476 | +2.59% | 180,000 | 125億2455万 | +13.33% |
| 06/01 | 463 | 468 | 459 | 464 | -0.64% | 108,500 | 122億881万 | +11.54% |
| 05/29 | 446 | 470 | 444 | 467 | +3.55% | 247,800 | 122億8775万 | +13.35% |
| 05/28 | 456 | 457 | 442 | 451 | -1.31% | 214,900 | 118億6675万 | +10.27% |
| 05/27 | 452 | 459 | 437 | 457 | +1.33% | 282,300 | 120億2462万 | +12.56% |
| 05/26 | 475 | 480 | 447 | 451 | -5.05% | 605,500 | 118億6675万 | +12.19% |
| 05/25 | 454 | 509 | 452 | 475 | +8.45% | 2,307,600 | 124億9824万 | +19.05% |
| 05/22 | 15:30 DW-5LBT pre NDA meetingのお知らせ |
| 05/22 | 436 | 447 | 432 | 438 | +0.69% | 320,800 | 115億2469万 | +10.89% |
| 05/21 | 432 | 442 | 422 | 435 | +0.69% | 243,800 | 114億4576万 | +10.97% |
| 05/20 | 418 | 434 | 414 | 432 | +2.13% | 238,200 | 113億6682万 | +11.05% |
| 05/19 | 420 | 426 | 412 | 423 | +1.93% | 275,400 | 111億3001万 | +9.59% |
| 05/18 | 393 | 415 | 391 | 415 | +5.87% | 201,800 | 109億1952万 | +8.36% |
| 05/15 | 401 | 406 | 379 | 392 | -1.51% | 285,300 | 102億9987万 | +3.16% |
| 05/14 | 15:30 2020年12月期第1四半期決算短信〔日本基準〕(連結) |
| 05/14 | 15:30 譲渡制限付株式報酬としての新株式の発行の払込完了に関するお知らせ |
| 05/14 | 412 | 422 | 396 | 398 | -5.01% | 276,700 | 104億5752万 | +5.57% |
| 05/13 | 430 | 431 | 408 | 419 | -1.41% | 313,700 | 110億930万 | +12.33% |
| 05/12 | 400 | 426 | 400 | 425 | +5.2% | 291,200 | 111億6696万 | +14.86% |
| 05/11 | 403 | 409 | 396 | 404 | +0.5% | 230,300 | 106億1518万 | +10.38% |
| 05/08 | 424 | 428 | 395 | 402 | -1.71% | 557,300 | 105億6263万 | +10.74% |
| 05/07 | 375 | 412 | 375 | 409 | +6.79% | 483,100 | 107億4655万 | +13.3% |
| 05/01 | 387 | 390 | 372 | 383 | -2.54% | 353,100 | 100億6340万 | +6.98% |
| 04/30 | 387 | 398 | 384 | 393 | +2.88% | 229,700 | 103億2615万 | +10.08% |
| 04/28 | 372 | 387 | 372 | 382 | +2.41% | 207,800 | 100億3712万 | +7.61% |
| 04/27 | 370 | 374 | 365 | 373 | +0.81% | 126,400 | 98億64万 | +5.67% |
| 04/24 | 375 | 377 | 366 | 370 | -1.07% | 117,500 | 97億2182万 | +5.41% |
